|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu AX: Systemic therapy of advanced
hepatocellular carcinoma: How hopeful should we be? Oncologist.
11:790–800. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Asghar U and Meyer T: Are there
opportunities for chemotherapy in the treatment of hepatocellular
cancer? J Hepatol. 56:686–695. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu F, Wang F, Yang T, Sheng Y, Zhong T and
Chen Y: Differential drug resistance acquisition to doxorubicin and
paclitaxel in breast cancer cells. Cancer Cell Int. 14:5382014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harada K, Ferdous T and Ueyama Y:
Establishment of 5-fluorouracil-resistant oral squamous cell
carcinoma cell lines with epithelial to mesenchymal transition
changes. Int J Oncol. 44:1302–1308. 2014.PubMed/NCBI
|
|
6
|
Haider M, Zhang X, Coleman I, Ericson N,
True LD, Lam HM, Brown LG, Ketchanji M, Nghiem B, Lakely B, et al:
Epithelial mesenchymal-like transition occurs in a subset of cells
in castration resistant prostate cancer bone metastases. Clin Exp
Metastasis. 33:239–248. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu H, Pirisi L and Creek KE: Six1
overexpression at early stages of HPV16-mediated transformation of
human keratinocytes promotes differentiation resistance and EMT.
Virology. 474:144–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dinicola S, Pasqualato A, Proietti S,
Masiello MG, Palombo A, Coluccia P, Canipari R, Catizone A, Ricci
G, Harrath AH, et al: Paradoxical E-cadherin increase in
5FU-resistant colon cancer is unaffected during
mesenchymal-epithelial reversion induced by γ-secretase inhibition.
Life Sci. 145:174–183. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou JZ and Jiang JX: Gap junction and
hemichannel-independent actions of connexins on cell and tissue
functions - an update. FEBS Lett. 588:1186–1192. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aasen T: Connexins: Junctional and
non-junctional modulators of proliferation. Cell Tissue Res.
360:685–699. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang JX and Gu S: Gap junction- and
hemichannel-independent actions of connexins. Biochim Biophys Acta.
1711:208–214. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Diezmos EF, Bertrand PP and Liu L:
Purinergic signaling in gut inflammation: The role of connexins and
pannexins. Front Neurosci. 10:3112016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cronier L, Crespin S, Strale PO, Defamie N
and Mesnil M: Gap junctions and cancer: New functions for an old
story. Antioxid Redox Signal. 11:323–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kandouz M and Batist G: Gap junctions and
connexins as therapeutic targets in cancer. Expert Opin Ther
Targets. 14:681–692. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Trosko JE and Ruch RJ: Gap junctions as
targets for cancer chemoprevention and chemotherapy. Curr Drug
Targets. 0.3:465–482. 2002. View Article : Google Scholar
|
|
16
|
Yu M, Zhang C, Li L, Dong S, Zhang N and
Tong X: Cx43 reverses the resistance of A549 lung adenocarcinoma
cells to cisplatin by inhibiting EMT. Oncol Rep. 31:2751–2758.
2014.PubMed/NCBI
|
|
17
|
Song J and Li Y: miR-25-3p reverses
epithelial-mesenchymal transition via targeting Sema4C in
cisplatin-resistance cervical cancer cells. Cancer Sci. Oct
15–2016.(Epub ahead of print). doi: 10.1111/cas.13104.
|
|
18
|
Gao HX, Yan L, Li C, Zhao LM and Liu W:
miR-200c regulates crizotinib-resistant ALK-positive lung cancer
cells by reversing epithelial-mesenchymal transition via targeting
ZEB1. Mol Med Rep. 14:4135–4143. 2016.PubMed/NCBI
|
|
19
|
Wu Q, Wang R, Yang Q, Hou X, Chen S, Hou
Y, Chen C, Yang Y, Miele L, Sarkar FH, et al: Chemoresistance to
gemcitabine in hepatoma cells induces epithelial-mesenchymal
transition and involves activation of PDGF-D pathway. Oncotarget.
4:1999–2009. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hiscox S, Jiang WG, Obermeier K, Taylor K,
Morgan L, Burmi R, Barrow D and Nicholson RI: Tamoxifen resistance
in MCF7 cells promotes EMT-like behaviour and involves modulation
of β-catenin phosphorylation. Int J Cancer. 118:290–301. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du B and Shim JS: Targeting
epithelial-mesenchymal transition (EMT) to overcome drug resistance
in cancer. Molecules. 21:212016. View Article : Google Scholar
|
|
22
|
Kay CW, Ursu D, Sher E and King AE: The
role of Cx36 and Cx43 in 4-aminopyridine-induced rhythmic activity
in the spinal nociceptive dorsal horn: An electrophysiological
study in vitro. Physiol Rep. 4:42016. View Article : Google Scholar
|
|
23
|
Unger VM, Kumar NM, Gilula NB and Yeager
M: Three-dimensional structure of a recombinant gap junction
membrane channel. Science. 283:1176–1180. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maes M, Decrock E, Cogliati B, Oliveira
AG, Marques PE, Dagli ML, Menezes GB, Mennecier G, Leybaert L,
Vanhaecke T, et al: Connexin and pannexin (hemi)channels in the
liver. Front Physiol. 4:4052014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
De Maio A, Gingalewski C, Theodorakis NG
and Clemens MG: Interruption of hepatic gap junctional
communication in the rat during inflammation induced by bacterial
lipopolysaccharide. Shock. 14:53–59. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sagawa H, Naiki-Ito A, Kato H, Naiki T,
Yamashita Y, Suzuki S, Sato S, Shiomi K, Kato A, Kuno T, et al:
Connexin 32 and luteolin play protective roles in non-alcoholic
steatohepatitis development and its related hepatocarcinogenesis in
rats. Carcinogenesis. 36:1539–1549. 2015.PubMed/NCBI
|
|
27
|
Nakashima Y, Ono T, Yamanoi A, El-Assal
ON, Kohno H and Nagasue N: Expression of gap junction protein
connexin32 in chronic hepatitis, liver cirrhosis, and
hepatocellular carcinoma. J Gastroenterol. 39:763–768. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao B, Zhao W, Wang Y, Xu Y, Xu J, Tang
K, Zhang S, Yin Z, Wu Q and Wang X: Connexin32 regulates hepatoma
cell metastasis and proliferation via the p53 and Akt pathways.
Oncotarget. 6:10116–10133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang J, Ichikawa A and Tsuchiya T: A novel
function of connexin 32: Marked enhancement of liver function in a
hepatoma cell line. Biochem Biophys Res Commun. 307:80–85. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Muramatsu A, Iwai M, Morikawa T, Tanaka S,
Mori T, Harada Y and Okanoue T: Influence of transfection with
connexin 26 gene on malignant potential of human hepatoma cells.
Carcinogenesis. 23:351–358. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Decrock E, Vinken M, De Vuyst E, Krysko
DV, Herde DK, Vanhaecke T, Vandenabeele P, Rogiers V and Leybaert
L: Connexin-related signaling in cell death: To live or let die?
Cell Death Differ. 16:524–536. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chandrasekhar A and Bera AK: Hemichannels:
Permeants and their effect on development, physiology and death.
Cell Biochem Funct. 30:89–100. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kar R, Batra N, Riquelme MA and Jiang JX:
Biological role of connexin intercellular channels and
hemichannels. Arch Biochem Biophys. 524:2–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Unahabhokha T, Chanvorachote P, Sritularak
B, Kitsongsermthon J and Pongrakhananon V: Gigantol Inhibits
Epithelial to Mesenchymal Process in Human Lung Cancer Cells. Evid
Based Complement Alternat Med. 2016:45616742016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Park SJ, Choi YS, Lee S, Lee YJ, Hong S,
Han S and Kim BC: BIX02189 inhibits TGF-β1-induced lung cancer cell
metastasis by directly targeting TGF-β type I receptor. Cancer
Lett. 381:314–322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou Q, Abraham AD, Li L, Babalmorad A,
Bagby S, Arcaroli JJ, Hansen RJ, Valeriote FA, Gustafson DL,
Schaack J, et al: Topoisomerase IIα mediates TCF-dependent
epithelial-mesenchymal transition in colon cancer. Oncogene.
35:4990–4999. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang HJ, Zhu J and Zheng GY: Role of
glutathione and other antioxidants in the inhibition of apoptosis
and mesenchymal transition in rabbit lens epithelial cells. Genet
Mol Res. 13:7149–7156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang J, Qiu M, Ma Y, Bu Y, Yang L and
Tang X: Advanced oxidation protein products induce
epithelial-to-mesenchymal transition in cultured human proximal
tubular epithelial cells via oxidative stress. Nan Fang Yi Ke Da
Xue Xue Bao. 34:659–663. 2014.(In Chinese). PubMed/NCBI
|
|
39
|
Ryoo IG, Shin DH, Kang KS and Kwak MK:
Involvement of Nrf2-GSH signaling in TGFβ1-stimulated
epithelial-to-mesenchymal transition changes in rat renal tubular
cells. Arch Pharm Res. 38:272–281. 2015. View Article : Google Scholar : PubMed/NCBI
|
